MedMen Enterprises(CNSX) MMEN

This security has been delisted. This page is retained for historical reference.

MedMen Enterprises last closing stock price
MetricPriceDate
Last closeCAD 0.022024-01-05
MedMen Enterprises stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-25%CAD 0.022023-12-29
1 month-25%CAD 0.022023-12-06
3 month-50%CAD 0.032023-10-05
Year to date-25%CAD 0.022023-12-29
1 year-40%CAD 0.032023-01-05
3 year-92.11%CAD 0.192021-01-05
5 year-99.68%CAD 4.652019-01-04
Since inception-99.7%CAD 4.952018-05-29

MMEN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

MMEN Financials

Key Financial Metrics (TTM)

Gross Margin

49.52%

Operating Margin

-43.53%

Net Income Margin

-117.57%

Return on Equity

-96.37%

Return on Capital

-11.19%

Return on Assets

-51.22%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$60.31M

Operating Income

-$28.61M

EBITDA

-$113.99M

Operating Cash Flow

-$20.35M

Capital Expenditure

-$11.47M

Free Cash Flow

-$31.81M

Cash & ST Invst.

$7.63M

Total Debt

$379.18M

MedMen Enterprises Performance Analysis

MedMen Enterprises annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 178,247,529N/A
MedMen Enterprises sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-06-30-5.5%
Q12022-09-30-9.8%
Q22022-12-31-1.6%
Q32023-03-31-7.9%
MedMen Enterprises annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -0.21N/A
MedMen Enterprises sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-06-30-309.3%
Q12022-09-3076.5%
Q22022-12-3125.6%
Q32023-03-31-100.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$27.22M

-22.8%

Gross Profit

$13.15M

-23.6%

Gross Margin

48.29%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

428

N/A

Net Income

-$31.21M

-60.3%

EBITDA

-$21.60M

-262.7%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Total Cash

$7.63M

-47.1%

Total Debt

$379.18M

-2.9%

Accounts Receivable

$3.86M

-58.9%

Inventory

$14.67M

+22.9%

Long Term Debt

$67.41M

-76.4%

Short Term Debt

$311.77M

+196.3%

Return on Assets

-51.22%

N/A

Return on Invested Capital

19.20%

N/A

Free Cash Flow

-$13.00M

-16.4%

Operating Cash Flow

-$14.84M

+6.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HEXO.TOHEXO Corp.
CA$0.88+1.15%
AEZS.TOAeterna Zentaris Inc.
CA$8.29+8.08%
THNK.VThink Research Corporation
CA$0.32+1.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
VEEAVeea
$6.17+169.43%
BITOProShares Trust - ProShares Bitcoin ETF
$10.22-3.72%
NOKNokia
$9.88+2.33%
AALAmerican Airlines Group
$12.80-2.33%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.